Almudena Martín‐Peña

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Manuela Aguilar‐Guisado, Ildefonso Espigado, Almudena Martín‐Peña et al. · The Lancet Haematology · 2017 · 230 citations

Antibiotics, Antimicrobial Stewardship, Phase 4 +9

Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications

Lorena López‐Cerero, M.D. Navarro, Mar Bellido et al. · Journal of Antimicrobial Chemotherapy · 2013 · 58 citations · Full text

Therapeutic Effect of the Acquisition of Cytomegalovirus-Specific Immune Response During Preemptive Treatment

Omar J. BenMarzouk‐Hidalgo, José Miguel Cisneros, Elisa Cordero et al. · Transplantation · 2011 · 52 citations

Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients

Almudena Martín‐Peña, Manuela Aguilar‐Guisado, Ildefonso Espigado et al. · Clinical Transplantation · 2010 · 44 citations

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

José Falantes, Cristina Calderón, Francisco J. Márquez‐Malaver et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 44 citations

Hematological Malignancy, Antibiotics, Antifungal Agents +10